Drug intelligence / Profile preview

nisin z

Development stage
Unknown
Lead developer
Handary
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral, Topical, Intravenous
01

Overview

Nisin Z is a naturally occurring antimicrobial peptide (lantibiotic) produced by the bacterium Lactococcus lactis. It is a variant of the well-known food preservative nisin and differs from the more common Nisin A by a single amino acid substitution (asparagine instead of histidine at position 27). Like other lantibiotics, it contains unusual amino acids such as lanthionine and methyllanthionine formed through posttranslational modification. Nisin Z exhibits broad-spectrum antibacterial activity against Gram-positive bacteria—including Bacillus, Clostridium, Listeria monocytogenes, Staphylococcus—and is used primarily as a natural food preservative to extend shelf life by inhibiting spoilage and pathogenic bacteria. Its mechanism involves depolarization of bacterial cytoplasmic membranes via pore formation. Recent research has also explored its antitumor potential and ability to enhance chemotherapeutic efficacy in cancer models. It has been shown to induce cell death in various cancer cell lines (e.g., non-small cell lung cancer, breast cancer) and may mitigate neuroinflammation associated with Alzheimer’s disease-like pathology[2][10]. Nisin Z is stable under acidic conditions and heat sterilization but insoluble in alkaline environments.

Brand names
NisinZNisin Z®NisinZ P
Other names
lantibiotic nisin-ZnisZ recombinant protein
02

Targets

Lipid II

Beyond the preview

Go deeper on nisin z.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nisin z.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call